Canada-based pharmacy retailing firm Jean Coutu Group has announced approval from the majority of its shareholders for its combination with food and pharmaceutical distribution company Metro.

The firms originally signed a definitive combination agreement in October, under which Metro would acquire all outstanding shares of Jean Coutu for a total of $4.5bn.

Through the deal, Metro is set to strengthen its footprint, operational efficiency and growth potential with the addition of more than 400 drugstores and a distribution centre.

“Our valued shareholders have overwhelmingly supported the Metro transaction.”

Upon completion of the transaction, Metro plans to operate Jean Coutu, as well as its own pharmacy distribution and franchising activities as a new wholly owned subsidiary.

The combined entity is estimated to include an overall network of more than 1,300 stores across the country.

It is expected to generate $16bn in revenues, $500m free cash flow and $75m in synergies in three years.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Jean Coutu Group’s board of directors chairman Jean Coutu said: “Our valued shareholders have overwhelmingly supported the Metro transaction.

“This strong support for the transaction shows that our shareholders understand the benefits they will receive as a result of this transaction, either by realising their investment or participating in the new combined entity, which is set to be a Canadian leader in the grocery and pharmaceutical industries.”

The deal is scheduled to complete next year and remains subject to approval from the Competition Bureau, the Toronto Stock Exchange, and the satisfaction or waiver of additional customary closing conditions.